Search for: "Hyman, Phelps & McNamara, P.C." Results 61 - 80 of 152
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Aug 2012, 4:22 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. is pleased to announce that Anne Walsh will moderate a panel on “Trends and Priorities in Enforcement” at this year’s Food and Drug Law Institute’s (“FDLI”) Advertising and Promotion Conference. [read post]
11 Jul 2012, 1:25 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. has prepared a detailed summary and analysis of FDASIA. [read post]
17 Jun 2012, 5:17 am by FDABlog HPM
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 - 2:00 p.m. [read post]
10 Jun 2012, 5:53 pm by FDABlog HPM
.), represented by Hyman, Phelps & McNamara, P.C., filed a food additive petition (Docket No. [read post]
10 May 2012, 3:26 pm by FDABlog HPM
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 - 2:00 p.m. [read post]
5 Mar 2012, 1:52 pm by FDABlog HPM
  We also thank our Hyman, Phelps & McNamara, P.C. colleagues for their time and dedication to writing interesting and informative posts. [read post]
27 Feb 2012, 7:14 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C., the nation’s largest boutique food and drug regulatory law firm, seeks an associate with one to five years experience in food, dietary supplement, and OTC drug laws and regulations to assist with a growing practice. [read post]
8 Feb 2012, 4:16 pm by FDABlog HPM
  At the conference, Chairman of the NORD Board of Directors and Hyman, Phelps & McNamara, P.C. [read post]
5 Feb 2012, 3:08 pm by FDABlog HPM
  Among other notable provisions, the proposed regulation would: Require states to convert to an actual acquisition cost basis for Medicaid prescription drug payment  Expand the MDRP to the U.S. territories Apply a statutory alternative rebate for line extensions of oral solid dosage form innovator drugs, not only to new formulations, but new indications, combination products, and products marketed by companies independent of the company marketing the original drug Limit wholesaler sales… [read post]
19 Jan 2012, 7:46 pm by FDABlog HPM
  On March 21, 2012 (12:30 - 2:00 PM ET), Hyman, Phelps & McNamara, P.C. will host a free webinar, titled “FDA Appeals - Improving Your Odds of Success; Trends, Expectations, Strategies. [read post]